Study targets stroke prevention in children with sickle cell anemia

Oct 28, 2009

St. Jude Children's Research Hospital investigators were recently awarded a $23 million federal grant to launch a national study of the drug hydroxyurea to prevent first strokes in children and adolescents with sickle cell anemia (SCA).

The effort will be the fifth at St. Jude involving hydroxyurea to treat children with SCA. The focus will be on SCA patients who have not suffered strokes but have been identified as high risk for the complication by transcranial Doppler ultrasound (TCD) screening. The five-year study is expected to include a total of 26 medical centers and about 140 patients.

"Our goal with this study is to prevent brain complications in with sickle cell disease," explained Russell Ware, M.D., Ph.D., principal investigator for the study, which is funded by the National Heart, Lung, and Blood Institute. Ware chairs the St. Jude Department of Hematology and holds the Lemuel Diggs Endowed Chair in Sickle Cell Disease.

SCA is an inherited . In the U.S., it is diagnosed most frequently in African American individuals. The sickled they produce can disrupt circulation and cause pain, strokes and other debilitating and sometimes deadly complications.

The new study is called TWiTCH, short for TCD With Transfusions Changing to Hydroxyurea. Patients will be randomly assigned to either continue a standard therapy of monthly blood transfusions and chelation to remove the resulting iron buildup or to receive a daily dose of and monthly phlebotomy to remove excess iron. The goal is to compare the two treatments, including their ability to prevent a first .

Source: St. Jude Children's Research Hospital

Explore further: Growing a blood vessel in a week

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Growing a blood vessel in a week

Oct 24, 2014

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

Oct 24, 2014

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments : 0